Skip to content

SANUWAVE Health, Inc. SNWV Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

The Beauty Health Company logo
The Beauty Health CompanySKIN
$0+100%

Other financials

Income statement

See full
Revenue$9.6M+3.1%
Gross profit$7.4M+0.8%
Operating income-$1.1M-287%
Net income-$1.4M+76.5%
EPS (diluted)-$0.17+76.4%

Balance sheet

See full
Cash & equivalents$10.8M+26.8%
Total debt$21.7M+5,319%
Total equity$1.8M+109%
Total assets$37.1M+20.2%

Cash flow

See full
Operating cash flow$397.0K+126%
CapEx$23.0K-85.8%
Free cash flow$374.0K+122%

Valuation

See full
Market cap$85.99M+10.0%
Enterprise value$96.88M
P/E5.2×
P/S1.9×

Profitability

See full
Gross margin76.7%+0.1pp
Operating margin7.3%-8.6pp
Net margin37.2%+21.6pp
FCF margin9%

Returns & leverage

See full
Return on equity-173.8%
Debt / equity11.8×
Current ratio1.3×+0.9×

Where this comes from

Reported directly by SANUWAVE Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: SANUWAVE Health, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SANUWAVE Health, Inc.'s fair value adjustment of warrants.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s fair value adjustment of warrants?
SANUWAVE Health, Inc. (SNWV) reported fair value adjustment of warrants of $0 in Q1 2026.
How has SANUWAVE Health, Inc.'s fair value adjustment of warrants changed year-over-year?
SANUWAVE Health, Inc.'s fair value adjustment of warrants decreased by 100.0% year-over-year, from $4.9M to $0.
What is the long-term trend for SANUWAVE Health, Inc.'s fair value adjustment of warrants?
Over 3 years (2021 to 2025), SANUWAVE Health, Inc.'s fair value adjustment of warrants has grown at a 45.7% compound annual growth rate (CAGR), from $2.62M to -$8.11M.
What does fair value adjustment of warrants mean?
This represents the periodic change in the fair value of derivative liabilities, specifically warrants, which must be marked-to-market each reporting period. Because these changes are non-cash, they are adjusted out of net income to arrive at operating cash flow. High volatility in this metric can significantly impact reported net income without affecting actual cash liquidity.